5JW5 | pdb_00005jw5

Structure of MEDI8852 Fab Fragment


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free: 
    0.217 (Depositor), 0.223 (DCC) 
  • R-Value Work: 
    0.187 (Depositor), 0.194 (DCC) 
  • R-Value Observed: 
    0.188 (Depositor) 

Starting Models: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5JW5

This is version 1.4 of the entry. See complete history

Literature

Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.

Kallewaard, N.L.Corti, D.Collins, P.J.Neu, U.McAuliffe, J.M.Benjamin, E.Wachter-Rosati, L.Palmer-Hill, F.J.Yuan, A.Q.Walker, P.A.Vorlaender, M.K.Bianchi, S.Guarino, B.De Marco, A.Vanzetta, F.Agatic, G.Foglierini, M.Pinna, D.Fernandez-Rodriguez, B.Fruehwirth, A.Silacci, C.Ogrodowicz, R.W.Martin, S.R.Sallusto, F.Suzich, J.A.Lanzavecchia, A.Zhu, Q.Gamblin, S.J.Skehel, J.J.

(2016) Cell 166: 596-608

  • DOI: https://doi.org/10.1016/j.cell.2016.05.073
  • Primary Citation Related Structures: 
    5JW3, 5JW4, 5JW5

  • PubMed Abstract: 

    Influenza virus remains a threat because of its ability to evade vaccine-induced immune responses due to antigenic drift. Here, we describe the isolation, evolution, and structure of a broad-spectrum human monoclonal antibody (mAb), MEDI8852, effectively reacting with all influenza A hemagglutinin (HA) subtypes. MEDI8852 uses the heavy-chain VH6-1 gene and has higher potency and breadth when compared to other anti-stem antibodies. MEDI8852 is effective in mice and ferrets with a therapeutic window superior to that of oseltamivir. Crystallographic analysis of Fab alone or in complex with H5 or H7 HA proteins reveals that MEDI8852 binds through a coordinated movement of CDRs to a highly conserved epitope encompassing a hydrophobic groove in the fusion domain and a large portion of the fusion peptide, distinguishing it from other structurally characterized cross-reactive antibodies. The unprecedented breadth and potency of neutralization by MEDI8852 support its development as immunotherapy for influenza virus-infected humans.


  • Organizational Affiliation
    • Department of Infectious Disease and Vaccines, MedImmune LLC, One MedImmune Way, Gaithersburg, MD 20878, USA.

Macromolecule Content 

  • Total Structure Weight: 95.02 kDa 
  • Atom Count: 7,333 
  • Modeled Residue Count: 862 
  • Deposited Residue Count: 874 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
MEDI8852 Heavy chainA [auth H],
C [auth A]
227Homo sapiensMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
MEDI8852 Light chainB [auth L],
D [auth B]
210Homo sapiensMutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free:  0.217 (Depositor), 0.223 (DCC) 
  • R-Value Work:  0.187 (Depositor), 0.194 (DCC) 
  • R-Value Observed: 0.188 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 65.22α = 90
b = 109.92β = 90
c = 139.89γ = 90
Software Package:
Software NamePurpose
XSCALEdata scaling
REFMACrefinement
PDB_EXTRACTdata extraction
XDSdata reduction
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-08-03
    Type: Initial release
  • Version 1.1: 2016-08-10
    Changes: Database references
  • Version 1.2: 2019-04-03
    Changes: Data collection, Source and taxonomy
  • Version 1.3: 2024-01-10
    Changes: Data collection, Database references, Refinement description
  • Version 1.4: 2024-11-20
    Changes: Structure summary